Literature DB >> 32569538

Reasons for Initiation of Areca Nut and Related Products in Patients with Oral Submucous Fibrosis within an Endemic Area in Gujarat, India.

Chandramani B More1, Naman Rajeshkumar Rao2,3, Sucheta More4, Newell W Johnson5,6.   

Abstract

Background: While the patterns of consumption of areca nut and its by-products (ANBP) vary across South Asia and the rest of the world, all users share the probable severe outcome of oral submucous fibrosis (OSMF), and this is well reported. The role of psychosocial drivers of habit initiation and addiction is reported less. Objective: To reveal the burden of ANBP abuse, exploring the psychosocial relationship between sex, age at first exposure (AFE), the reason for initiation (RFI) with the type of habit (TOH). Methodology: Data came from the prospective hospital-based study conducted at K.M. Shah Dental College and Hospital covering years 2017 and 2018. Patients with oral lesions were assessed with complete history recording demographics, TOH, AFE, RFI, duration of habit, and clinical diagnosis of any oral and systemic diseases. Patients with a history of scleroderma, facial burns, and oral malignancy were excluded.
Results: Of the 13,874 patients, 9.89% reported ANBP. We included 1000 OSMF patients. The mean age of the study cohort was 38.97 ± 14.29 years, with a range of 17-75 years. Males constituted the majority (80.1%). The most common TOH reported was regular use of gutkha (60.1%) followed by mawa (31.4%) with tension and stress (30.3%) being the most common RFI among the cohort. TOH was notably different in relation to AFE. Interestingly, mawa chewing (38.69%) was observed more in females. Importance: This study reveals the burden of ANBP abuse and reports the complex psychosocial relationships between sex, AFE, and RFI with TOH in OSMF patients in this high incidence population.

Entities:  

Keywords:  Areca nut and its byproduct abuse; oral submucous fibrosis; psychosocial effects

Mesh:

Year:  2020        PMID: 32569538     DOI: 10.1080/10826084.2019.1660678

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  6 in total

1.  Causal inference and directed acyclic graph: An epidemiological concept much needed for oral submucous fibrosis.

Authors:  Naman R Rao; Chandramani B More; Rahi M Brahmbhatt; Youbai Chen; Wai-Kit Ming
Journal:  J Oral Biol Craniofac Res       Date:  2020-07-03

Review 2.  Efficacy of lycopene in management of Oral Submucous Fibrosis- A systematic review and meta-analysis.

Authors:  Neha Gupta; Ashita Kalaskar; Ritesh Kalaskar
Journal:  J Oral Biol Craniofac Res       Date:  2020-09-17

3.  Biochemical status of serum iron in histopathological grades of oral submucous fibrosis.

Authors:  Toniya Raut; Shashi Keshwar; Jyotsna Rimal; Madhab Lamsal; Ashish Shrestha
Journal:  J Oral Biol Craniofac Res       Date:  2020-10-19

4.  Evaluation of serum immunoglobulin (IgG, IgM, IgA) in potentially malignant disorders of oral cavity - A case control study.

Authors:  Vivek M Tarsariya; Dhaval N Mehta; Nilesh Raval; Hiren H Patadiya; Kanan Vachhrajani; Albert Ashem
Journal:  J Oral Biol Craniofac Res       Date:  2020-09-08

5.  Medicinal management of oral submucous fibrosis in the past decade- A systematic review.

Authors:  Chandramani B More; Deepa Jatti Patil; Naman R Rao
Journal:  J Oral Biol Craniofac Res       Date:  2020-08-19

Review 6.  Laser as a promising non-invasive technique to treat oral submucous fibrosis: A systematic review of the literature.

Authors:  Sonia Gupta; Manveen Kaur Jawanda
Journal:  Saudi Dent J       Date:  2020-11-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.